1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > Canada Immuno Chemistry Market Outlook to 2021

Canada Immuno Chemistry Market Outlook to 2021

  • August 2015
  • -
  • GlobalData
  • -
  • 83 pages

Canada Immuno Chemistry Market Outlook to 2021

Summary

GlobalData’s new report, "Canada Immuno Chemistry Market Outlook to 2021", provides key market data on the Canada Immuno Chemistry market. The report provides value, in millions of US dollars within market segments - Anemia Tests, Vitamins Tests, Disease Specific Immunochemistry, Endocrinology Tests, Immunochemistry Analyzers, Immunochemistry Rapid Tests & POC, IgE Allergy Blood Tests and Specific Proteins.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Immuno Chemistry market includes Anemia Tests, Vitamins Tests, Disease Specific Immunochemistry, Endocrinology Tests, Immunochemistry Analyzers, Immunochemistry Rapid Tests & POC, IgE Allergy Blood Tests and Specific Proteins.
- Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Immuno Chemistry market.
- Global corporate-level profiles of key companies operating within the Canada Immuno Chemistry market.
- Key players covered include Siemens Healthcare, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Alere Inc., Ortho-Clinical Diagnostics Inc. and Abbott Laboratories.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table Of Contents

Canada Immuno Chemistry Market Outlook to 2021
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 What Is This Report About? 6
2.2 Immuno Chemistry Market Segmentation 6
2.3 Definitions of Markets Covered in the Report 7
3 Immuno Chemistry Market, Canada 12
3.1 Immuno Chemistry Market, Canada, Revenue ($m), 2007-2014 12
3.2 Immuno Chemistry Market, Canada, Revenue ($m), 2014-2021 14
3.2.1 Anemia Tests Market, Canada, Revenue ($m), by Segment, 2007-2014 16
3.2.2 Disease Specific Immunochemistry Market, Canada, Revenue ($m), by Segment, 2007-2014 18
3.2.3 Endocrinology Tests Market, Canada, Revenue ($m), by Segment, 2007-2014 20
3.2.4 IgE Allergy Blood Tests Market, Canada, Revenue ($m), by Segment, 2007-2014 22
3.2.5 Immunochemistry Analyzers Market, Canada, Revenue ($m), by Segment, 2007-2014 24
3.2.6 Immunochemistry Rapid Tests and POC Market, Canada, Revenue ($m), by Segment, 2007-2014 26
3.2.7 Vitamins Tests Market, Canada, Revenue ($m), by Segment, 2007-2014 28
3.2.8 Anemia Tests Market, Canada, Revenue ($m), by Segment, 2014-2021 30
3.2.9 Disease Specific Immunochemistry Market, Canada, Revenue ($m), by Segment, 2014-2021 32
3.2.10 Endocrinology Tests Market, Canada, Revenue ($m), by Segment, 2014-2021 34
3.2.11 IgE Allergy Blood Tests Market, Canada, Revenue ($m), by Segment, 2014-2021 36
3.2.12 Immunochemistry Analyzers Market, Canada, Revenue ($m), by Segment, 2014-2021 38
3.2.13 Immunochemistry Rapid Tests and POC Market, Canada, Revenue ($m), by Segment, 2014-2021 40
3.2.14 Vitamins Tests Market, Canada, Revenue ($m), by Segment, 2014-2021 42
3.3 Immuno Chemistry Market, Canada, Distribution Share by Revenue ($m), 2013-2014 44
3.4 Immuno Chemistry Market, Canada, Company Share by Revenue ($m), 2014 45
4 Overview of Key Companies in Canada, Immuno Chemistry Market 47
4.1 Siemens Healthcare 47
4.1.1 Company Overview 47
4.2 Abbott Laboratories 47
4.2.1 Company Overview 47
4.3 F. Hoffmann-La Roche Ltd. 47
4.3.1 Company Overview 47
4.4 Alere Inc. 48
4.4.1 Company Overview 48
4.5 Thermo Fisher Scientific Inc. 48
4.5.1 Company Overview 48
4.6 Ortho-Clinical Diagnostics Inc. 48
4.6.1 Company Overview 48
4.7 bioMerieux S.A. 49
4.7.1 Company Overview 49
4.8 Bio-Rad Laboratories, Inc. 49
4.8.1 Company Overview 49
4.9 PerkinElmer, Inc. 49
4.9.1 Company Overview 49
4.10 Biomedica Diagnostics Inc. 50
4.10.1 Company Overview 50
5 Immuno Chemistry Market Pipeline Products 51
6 Financial Deals Landscape 57
6.1 Acquisition 57
6.1.1 Empire Genomics Acquires ID Labs 57
6.2 Partnerships 58
6.2.1 Abcam Enters into Co-Marketing Agreement with Cell Marque for IVD IHC RabMAb Antibodies 58
7 Recent Developments 59
7.1 Corporate Communications 59
7.1.1 May 19, 2015: Response Biomedical Announces the Appointment of Dr. Barbara Kinnaird Ph.D. as Chief Executive Officer and Voting Results from its 2015 AGM 59
7.1.2 Jan 27, 2015: Miraculins Announces Retail Pharmacy Pilot for its Scout DS Diabetes Screen 59
7.1.3 Sep 16, 2014: Response Biomedical Announces Series Of Management Changes 61
7.1.4 Aug 28, 2014: Response Biomedical Announces New Chairman of the Board 62
7.1.5 Aug 12, 2014: Esperion Therapeutics Provides ETC-1002 Development Program Update 62
7.2 Financial Announcements 62
7.2.1 Jun 12, 2015: DiagnoCure announces second quarter 2015 results and restructures its Board of directors 62
7.2.2 May 05, 2015: Response Biomedical Announces First Quarter 2015 Financial Results 63
7.2.3 Mar 16, 2015: Response Biomedical Announces Fourth Quarter and Fiscal 2014 Financial Results 64
7.2.4 Mar 06, 2015: DiagnoCure announces first quarter 2015 results 66
7.2.5 Jan 27, 2015: InspireMD Receives CE Mark Approval for Its New CGuard RX and Announces Positive Six Month Follow-Up CARENET Trial Data at LINC 2015 67
7.2.6 Jan 23, 2015: DiagnoCure announces fourth quarter 2014 and year-end results 69
7.2.7 Jan 15, 2015: United Health Products to Launch HemoStrip Adhesive Bandage to Retail Market 71
7.2.8 Nov 24, 2014: Volpara Solutions to Launch VolparaAnalytics 1.2 at RSNA 71
7.2.9 Nov 10, 2014: Response Biomedical Announces Third Quarter 2014 Financial Results 72
7.2.10 Sep 11, 2014: DiagnoCure announces results for third quarter of 2014 74
7.2.11 Aug 11, 2014: Response Biomedical Announces Second Quarter 2014 Financial Results 75
7.3 Other Significant Developments 76
7.3.1 Apr 23, 2015: DiagnoCure provides business up-date 76
7.3.2 Feb 06, 2015: Response Biomedical Announces Expansion of Chinese Distribution Agreement for RAMP Cardiovascular Products 77
7.3.3 Nov 03, 2014: Response Biomedical Provides Update On Term Loan 78
7.3.4 Oct 15, 2014: Response Biomedical Announces Funded Program And Equity Investment By Leading Chinese Medical Device Company 78
7.4 Product News 79
7.4.1 Jul 22, 2015: ImmunID Key Technology Patents Covering ImmunTraCkeR and ImmunIG Granted in the United States, Europe, Canada and Japan 79
8 Appendix 80
8.1 Research Methodology 81
8.1.1 Coverage 81
8.1.2 Secondary Research 81
8.1.3 Primary Research 82
8.1.4 Company Share Analysis 82
8.1.5 Distribution Share Analysis 82
8.2 GlobalData Consulting 82
8.3 Contact Us 83
8.4 Disclaimer 83

1.1 List of Tables
Table 1: Immuno Chemistry Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 13
Table 2: Immuno Chemistry Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 15
Table 3: Anemia Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 17
Table 4: Disease Specific Immunochemistry Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 19
Table 5: Endocrinology Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 21
Table 6: IgE Allergy Blood Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 23
Table 7: Immunochemistry Analyzers Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 25
Table 8: Immunochemistry Rapid Tests and POC Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 27
Table 9: Vitamins Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 29
Table 10: Anemia Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 31
Table 11: Disease Specific Immunochemistry Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 33
Table 12: Endocrinology Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 35
Table 13: IgE Allergy Blood Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 37
Table 14: Immunochemistry Analyzers Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 39
Table 15: Immunochemistry Rapid Tests and POC Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 41
Table 16: Vitamins Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 43
Table 17: Immuno Chemistry Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2013-2014 44
Table 18: Immuno Chemistry Market, Canada, Company Share by Revenue ($m), USD Constant, 2014 46
Table 19: Immuno Chemistry Market Pipeline Products 51
Table 20: Empire Genomics Acquires ID Labs 57
Table 21: Abcam Enters into Co-Marketing Agreement with Cell Marque for IVD IHC RabMAb Antibodies 58

1.2 List of Figures
Figure 1: Immuno Chemistry Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 12
Figure 2: Immuno Chemistry Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 14
Figure 3: Anemia Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 16
Figure 4: Disease Specific Immunochemistry Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 18
Figure 5: Endocrinology Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 20
Figure 6: IgE Allergy Blood Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 22
Figure 7: Immunochemistry Analyzers Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 24
Figure 8: Immunochemistry Rapid Tests and POC Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 26
Figure 9: Vitamins Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 28
Figure 10: Anemia Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 30
Figure 11: Disease Specific Immunochemistry Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 32
Figure 12: Endocrinology Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 34
Figure 13: IgE Allergy Blood Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 36
Figure 14: Immunochemistry Analyzers Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 38
Figure 15: Immunochemistry Rapid Tests and POC Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 40
Figure 16: Vitamins Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 42
Figure 17: Immuno Chemistry Market, Canada, Company Share (%) 2014 45

Companies Mentioned
Siemens Healthcare
Abbott Laboratories
F. Hoffmann-La Roche Ltd.
Alere Inc.
Thermo Fisher Scientific Inc.
Ortho-Clinical Diagnostics Inc.
bioMerieux S.A.
Bio-Rad Laboratories, Inc.
PerkinElmer, Inc.
Biomedica Diagnostics Inc.

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017-2021 Enteric Diseases Diagnostic Testing Market

2017-2021 Enteric Diseases Diagnostic Testing Market

  • $ 7500
  • Industry report
  • February 2017
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...

2017-2021 Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia--Supplier Shares, Competitive Strategies

2017-2021 Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia--Supplier Shares, Competitive Strategies

  • $ 7500
  • Industry report
  • January 2017
  • by Venture Planning Group

About this Report This new 389-page report from VPGMarketResearch.com presents detailed analysis of the Enteric Disease market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan.  Current ...

2017-2021 World Enteric Disease Market: Global Opportunities and Growth Strategies

2017-2021 World Enteric Disease Market: Global Opportunities and Growth Strategies

  • $ 7500
  • Industry report
  • February 2017
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.